169 related articles for article (PubMed ID: 3459391)
21. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Fernandez-Guerrero M; Rouse M; Henry N; Wilson W
Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
[TBL] [Abstract][Full Text] [Related]
22. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
Climo MW; Patron RL; Goldstein BP; Archer GL
Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
[TBL] [Abstract][Full Text] [Related]
23. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Galetto DW; Boscia JA; Kobasa WD; Kaye D
J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
Antimicrob Agents Chemother; 1998 Feb; 42(2):254-6. PubMed ID: 9527768
[TBL] [Abstract][Full Text] [Related]
25. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.
Nicolau DP; Freeman CD; Nightingale CH; Coe CJ; Quintiliani R
Antimicrob Agents Chemother; 1994 Jul; 38(7):1515-8. PubMed ID: 7979281
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Barriere SL; Albrecht LM; Rybak MJ
Antimicrob Agents Chemother; 1990 Feb; 34(2):257-60. PubMed ID: 2327773
[TBL] [Abstract][Full Text] [Related]
27. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.
Jacqueline C; Batard E; Perez L; Boutoille D; Hamel A; Caillon J; Kergueris MF; Potel G; Bugnon D
Antimicrob Agents Chemother; 2002 Dec; 46(12):3706-11. PubMed ID: 12435665
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.
Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P
Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584
[TBL] [Abstract][Full Text] [Related]
31. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
[TBL] [Abstract][Full Text] [Related]
32. Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1987 Mar; 31(3):458-60. PubMed ID: 3472489
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
Antimicrob Agents Chemother; 1998 Apr; 42(4):981-3. PubMed ID: 9559828
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
Kim YS; Liu Q; Chow LL; Chambers HF; Täuber MG
Antimicrob Agents Chemother; 1998 Dec; 42(12):3325-7. PubMed ID: 9835540
[TBL] [Abstract][Full Text] [Related]
35. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
Berry AJ; Johnston JL; Archer GL
Antimicrob Agents Chemother; 1986 May; 29(5):748-52. PubMed ID: 3460523
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
Cantoni L; Glauser MP; Bille J
Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
[TBL] [Abstract][Full Text] [Related]
37. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
Chandrasekar PH; Levine DP; Price S; Rybak MJ
J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
[TBL] [Abstract][Full Text] [Related]
38. CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Lamp KC; Bailey EM; Rybak MJ
Antimicrob Agents Chemother; 1992 Jun; 36(6):1192-7. PubMed ID: 1329613
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Chambers HF
Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
[TBL] [Abstract][Full Text] [Related]
40. Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
García-de-la-Mària C; Marco F; Armero Y; Soy D; Moreno A; del Río A; Almela M; Cervera C; Ninot S; Falces C; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2010 Jul; 54(7):2781-6. PubMed ID: 20421394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
